The proto-oncogene Fli-1, a member of Ets family is rearranged or activated through proviral integration in erythroleukemias, induced by Friends' Murine Leukemia Virus. The DNA binding domain (ETS domain) of Fli-1 is fused to the RNA binding domain of EWS by t(11q24:22q12) chromosomal translocation in Ewing's sarcoma and primitive neuroectodermal tumors. Screening of human cDNA libraries has identi®ed two dierent 5'-termini and alternatively spliced forms of the human Fli-1 gene (Fli-1b), suggesting the possible existence of two independent promoters. The genomic sequence adjacent to the alternate exon of human Fli-1b gene shows functional promoter activity when cloned in promoter-less CAT expression vector and transfected into QT-6 cells. The transcription initiation (CAP) site and minimum promoter region necessary for function were localized. The 5'-¯anking regions of human Fli-1b and mouse Fli-1 show 80% homology suggesting conserved promoter regulatory elements. The Fli-1b 5'-anking sequence lacks canonical TATA or CCAAT boxes but contains a partially conserved TATA-like sequence at position 242. Several transcription factor binding sequences like ATF/CREB, E2A-PBX1, EBP, PEA-3, ETS-2, Sp-1, c-Myc, TBP, GATA-1 and Oct-3 were conserved in the promoter sequence. Functional promoter assays revealed that Fli-1b promoter shows very strong transcriptional activation compared to Fli-1 promoter. We also showed that variant Fli-1b has transcriptional activation properties similar to those of Fli-1. Fli-1b and Fli-1 show dierential expression in various hematopoietic cell lines. This dierential expression and promoter activities of Fli-1 and Fli-1b suggests that several mechanisms are involved in Fli-1 gene regulation which are mediated by many transcription factors.
Introduction
The proto-oncogene, Fli-1 is rearranged in Friend MuLV induced erythroleukemias (Ben-David et al., 1990 and other non-B and non-T leukemias induced by Cas-Br-E (Bergeron et al., 1992) . Analyses of human and mouse Fli-1 cDNA sequences placed them in the ETS gene family which shows high homology within their DNA binding (ETS) domain (Ben-David et al., 1991; Prasad et al., 1992) and codes for dierent sequence-speci®c transcriptional activators. The superfamily of ETS genes includes several members: c-ets-1 (Reddy and Rao, 1988; Chen, 1988) , ets-2 Boulukos et al., 1988) , erg Rao et al., 1987) , Elk-1 and Elk-2 (Rao et al., 1989) , Pu.1/Spi-1 and Spi-1B (Goebl et al., 1990; Klemsz et al., 1990; Ray et al., 1992) , E-74 (Burtis et al., 1990) Sap-1 and Sap-2 (Dalton and Triesman, 1992) , GABP a (LaMarco et al., 1991) , Elf-1 , PEA-3 (Xin et al., 1992) , Fli-1 (Ben-David et al., 1990; Prasad et al., 1992) , D-elg (Pribyl et al., 1988) , ER-81 and ER-71 (Brown and McKnight, 1992) , Tel (Golub et al., 1994) , ERP (Lopez et al., 1994) and ETV-1 (Jeon et al., 1995) . Most of the ETS proteins are related to each other by virtue of their Etsdomain, a 85-residue region capable of binding to speci®c DNA binding sequences. They may also share additional homologous regions like Ets-1/Ets-2 and erg Watson et al., 1988; Thompson et al., 1991) . Ets proteins bind to purine rich GGAA/T core DNA sequences of which thē anking sequences on both sides determine anity and speci®city (Seth et al., 1993; Janknecht and Nordheim, 1992) . Ets proteins can bind with variable anities to overlapping target sequences if not identical sequences (Dalton and Triesman, 1992; LaMarco et al., 1991; Thompson et al., 1992; Reddy and Rao, 1991; Rao and Reddy, 1992a) . Ets proteins have been shown to exhibit sequencespeci®c transcriptional activation Rao and Reddy, 1992a; Bosselut et al., 1990; Gunther et al., 1990; Wasylyk et al., 1990) , cooperate with other nuclear oncogenes (Wasylyk et al., 1990; Dudek et al., 1992) and form nucleoprotein complexes through protein-protein interactions (Dalton and Triesman, 1992; Rao and Reddy, 1992a,b; Hipskind et al., 1991) .
Analysis of mouse erythroleukemias induced by spleen focus-forming virus (SFFV) revealed a preferred proviral insertion resulting in the activation of the ets gene, Spi-1 MoreauGachelin et al., 1989) . Similarly, in erythroleukemias induced by Friend-Murine leukemia virus (F-MuLV) another ets family member Fli-1 (Ben-David et al., 1990 is preferentially inserted and activated. Interestingly, Spi-1 is not found to be rearranged in erythroleukemias induced by F-MuLV nor is Fli-1 shown to be rearranged in SFFV-induced leukemias, suggesting the high speci®city of integration/activation of these genes. Mouse Fli-1 locus has been localized to chromosome 9 and its human homologue to chromosome 11, syntenic with mouse chromosome (Ben-David et al., 1991; Delattre et al., 1992; Baud et al., 1991) , frequently involved in rearrangements in many human leukemias, lymphomas and sarcomas (Haluska et al., 1986; Yunis et al., 1986; Selleri et al., 1991) .
The Fli-1 gene has been recently shown to be rearranged in a majority of cases of Ewing's family of tumors that share t(11:22) chromosome translocation (Delattre et al., 1992) . Molecular characterization of these Ewing family of tumors revealed fusion of the EWS gene on chromosome 22, with either Fli-1 or erg genes located on chromosomes 11 and 21 respectively. Previously Fli-1 and Erg genes have been cloned by us and others (Ben-David et al., 1991; Prasad et al., 1992; Reddy et al., 1987) and the functional analysis of these proteins revealed that these proteins code for sequence-speci®c transcriptional activators with two transactivation domains present at amino-and carboxy-termini (Siddique et al., 1993; Rao et al., 1993) . We and others have shown that EWS-Fli-1 and EWS-erg proteins encode transcriptional activators Baily et al., 1994) and these aberrant proteins show altered DNA binding and transactivation properties compared to normal Fli-1 and erg proteins. We have shown earlier that Fli-1 and erg proteins inhibit apoptosis, suggesting that activation of these genes in leukemias and lymphomas may have led to deregulation of apoptosis (Yi et al., 1997) .
Despite the involvement of the Fli-1 gene in oncogenesis and in chromosomal translocation/rearrangements, little is known about its regulation. In this report we show that human Fli-1 gene is alternatively spliced and that the splice variant (Fli1b) encodes a sequence-speci®c transcriptional activator with high level expression in pre-B cells. In addition, we have also isolated and characterized alternate functional Fli-1 promoter for alternatively spliced human Fli-1b transcript, and we have identi®ed several conserved transcription factorbinding sites, which may be involved in the functional regulation of Fli-1 gene.
Results
Isolation and expression of Fli-1b, an alternatively spliced human Fli-1 cDNA Molt-4 and spleen cDNA libraries were screened with erg probe and many positive clones were isolated. Sequence and PCR analyses of these cDNAs revealed that two of these clones (lambda 3 and lambda 4) code for full-length human Fli-1 protein, as we described earlier (Prasad et al., 1992) . Analysis of other positive clones revealed that one of these clones (Lambda 7) codes for a variant Fli-1 protein, named Fli-1b. Sequence analysis of the Fli-1b cDNA indicated that the sequence was identical to the normal Fli-1 gene, except at the 5'-end of the gene, where an alternative splicing was observed. It contained a deletion at the 5'-end and lacks the ®rst exon, which encodes for ®rst six amino acids (MDGTIK) and 5'-UTR of the Fli-1 gene (Prasad et al., 1992) . Previously, we have shown that the 5'-untranslated region of the human Fli-1 gene is 95% homologous to the 5'-untranslated region of the mouse Fli-1 gene. Surprisingly, the 5'-untranslated region of splice variant Fli-1b gene also showed high homology with the 5'-sequences of mouse Fli-1 reported recently (Barbeau et al., 1996) . Figure 1 shows the partial 5'-sequences of human Fli-1b and its homology with human and mouse Fli-1 genomic sequences. The human Fli-1 gene encodes 452 residue polypeptide. The splice variant Fli-1b gene codes for a shorter protein with a primary length of 419 amino acids. The¯aking sequences of the putative initiation site (ATG at nt 272) show an almost perfect match with Kozak's consensus sequence (CCGACAUG) . This codon appears to be the right initiation codon because two stop codons are present in the reading frame upstream of this codon.
In order to test whether the deduced open reading frame agrees with the expressed Fli-1b protein, full length Fli-1 and Fli-1b cDNAs were sub-cloned into pSG5 vector, linearized with appropriate restriction enzymes, in vitro transcribed and translated. The expressed proteins were characterized on 10% SDS ± Figure 1 Homology of human Fli-1b cDNA with human and mouse Fli-1 genomic DNA sequences. Human Fli-1b cDNA (top) compared with human (middle) and mouse (bottom) genomic DNA sequences (Barbeau et al., 1996) . The ®rst nine amino acids of human Fli-1b are shown at the bottom of the sequence. Splice junction is indicated by arrow. Asterisks represent stop codons at the upstream region of a translation initiation site Fli-1b encodes a transcriptional activator PDK Dhulipala et al PAGE (Figure 2a) . The full length Fli-1 and splice variant Fli-1b proteins were expressed as 55 kD and 52 kD proteins respectively, close to the predicted masses from sequence analysis. A small dierence observed between the deduced and actual molecular weight of the Fli-1 proteins may be because of the presence of high proline content. A similar phenomenon was observed with Erg-2 and Elk-1 proteins (Rao et al., , 1989 . The expression of splice variant Fli-1b mRNA was examined by Northern blot analysis of Poly(A) + RNAs isolated from Molt-4 (human T-cell acute lymphoblastic leukemia), Colo 320 (human colon adenocarcinoma), KG-1 (human acute myelogenous leukemia) and 697 (human pre-B cell acute lymphocytic leukemia) cells. The blot was probed with Fli-1b speci®c 5'-untranslated probes as described in Materials and methods. The Fli-1 probe was found to hybridize with a 3.6 kb transcript in all the RNAs tested (results not shown), whereas interestingly, the Fli-1b probe hybridized to the same size transcript only in 697 (human pre-B cell acute lymphocytic leukemia) cellular RNA (Figure 2b ), indicating that Fli-1b shows high level expresson in pre-B cells. We have also con®rmed the expression of Fli-1b in another pre-B cell acute lymphocytic leukemia line RCH-ACV (data not shown).
Human Fli-1b functions as sequence-speci®c transcriptional activator
Previously we have shown that human Fli-1 and its related erg-2, erg-3 proteins act as sequence-speci®c transcriptional activators Siddique et al., 1993; Rao et al., 1993; Prasad et al., 1994 ). Here, we tested whether Fli-1b which lacks the ®rst exon can also act as a transcriptional activator. Full length Fli-1 and splice variant Fli-1b cDNAs were cloned in pSG5 vector and were used along with erg-2 and erg-3 expression vectors to study their transcriptional activation. These expression plasmids were cotransfected with b-galactosidase reference plasmid (pCH 110) and E74-TK-CAT reporter plasmid, which contains three copies of Fli-1 target sequences (of E74 gene) upstream of thymidine kinase promoter in NIH3T3 cells. Both Fli-1 and Fli-1b expression plasmids showed 10 ± 11-fold activity ( Figure 2c ). These results suggest that human Fli-1b also activates the promoter linked to the target sequence and can function as a transcriptional activator.
Determination of 5'-end (CAP sites) of Fli-1b mRNA
The determination of the CAP site of Fli-1b mRNA was performed by 5'-RACE PCR ampli®cation using the anchor primer and Fli-1b gene-speci®c antisense primer (complementary to nt 785 to 7105) and sequencing the RACE product and hybridizing the product with Fli-1b 5-end probe (Figure 4 ). Two major initiation sites were observed with Fli-1b mRNA. The upstream CAP site was designated as +1 and the second site was present at nucleotide 107 ( and Fli-1b may be due to the usage of internal initiation codon Rao et al., 1987 and Prasad et al., 1994) . (b) Expression of human Fli-1b mRNA. Poly(A) + RNAs were isolated from various cell lines and were electrophoresed on 1.2% formaldehyde agarose gels along with an RNA ladder, transferred on to nytran membranes. The ®lters were probed with 32 P-labeled Fli-1b-speci®c 5'-untranslated region probes as described in Materials and methods. Lane 1: Molt 1; lane 2: Colo-320; lane 3: 697; lane 4: KG-1. Sizes of the marker RNAs is shown on right. (c) The human Fli-1b protein is a transcriptional activator. NIH3T3 cells were transfected with empty pSG5 vector or with vectors expressing Fli-1, Fli-1b, erg 2 or erg 3 proteins along with reporter plasmid E74-TK-CAT (containing three copies of Fli-1 target sequences) and a reference plasmid pCH110 as described . CAT assays were performed on cell lysates 60 h after transfection. The experiments were carried out in duplicates at least three times. Lane 1: E74-TK-CAT reporter plasmid; lane 2: E74-TK-CAT+pSG5 vector; lane 3: E74-TKCAT+Fli-1; lane 4: E74-TK-CAT+Fli-1b; lane 5: E74-TKCAT+erg 2; lane 6: E74-TK-CAT+erg 3. Fold activity +mean values were given for each lane further characterized by restriction mapping. The HGL #2 clone, with &6 kb insert was found to hybridize with the probe speci®c for the Fli-1b 5'-untranslated region. A restriction map for this clone was generated by Southern hybridizations and restriction analysis (Figure 3a ). An approximately 6 kb EcoRI fragment from this clone was subcloned into pBluescript, KS + and sequenced. An &3 kb XbaI fragment containing the putative promoter for Fli-1b was subcloned in promote-less-CAT vector and successive 5'-end deletion constructs were made by PCR. The sequence of the putative Fli-1b promoter region is shown in Figure 3b .
Promoter elements
Analysis of the 5'-upstream sequences of Fli-1b revealed the presence of various conserved transcription factor-binding sites which have been reported to regulate other promoter regions. Elements showing high or full homology to the consensus sequences are + RNA were prepared from 697 and KG-1 cells and single strand cDNAs were prepared using a 5'-RACE kit (Clontech) and Fli-1 gene-speci®c primer (5'-GCTGCCCGTAGT-CAGGACTC-3') and ligating anchor primer at the 5'-end using RNA ligase enzyme. The 5'-cDNA ends were obtained by ampli®cation of the template using an Fli-1b gene-speci®c antisense primer and anchor primer (Clontech) as sense primer as described in Materials and methods. shown (Figure 3b ). No canonical TATA or CCAAT boxes were found in the Fli-1b promoter region. However, two TATA box consensus sequences were observed at positions 242 and 348. In both cases, ®ve nucleotides out of six were conserved (Figure 3b ). The TATA-like consensus sequences were conserved between human and mouse sequences and one of them (at position 242) could represent a functional TATA box leading to transcription initiation from the identi®ed CAP sites. Comparison of 5'-¯anking sequence of Fli-1b by the BLAST program (results not shown) also revealed that a 696 bp region extending from 7280 to +416 shows an 82 ± 98% homology with mouse Fli-1 5'-¯aking region at dierent regions and a 98% homology (position 71154 to +346) with human Fli-1 5'-¯anking sequences (Barbeau et al., 1996) . Analysis of human Fli-1b promoter sequences identi®ed several consensus sequences for transcription factor binding sites (Figure 3b ). The promoter region contains two Sp-1 sites at 757 and +87 at close proximity to CAP sites and another site at position 7508. The Sp-1 sequences have been implicated in transcriptional activation of TATA-less promoters present in housekeeping genes and proto-oncogenes (Dynan et al., 1986) . Multiple purine rich GGAA Ets Binding Sites (EBS) were identi®ed (at positions 7653, 7349 and 7278) in the human Fli-1b promoter . One of them at position 7278 also overlaps with binding sites for other Ets transcription factors, PEA-3 and Elk-1. We have also identi®ed two target consensus target sequences (at position 71076 and 725) of E2A-PBX1 fusion protein involved in pre-B cell acute lymphoblastic leukemias carrying the t(1;19) chromosomal translocation. Since Fli-1b is expressed at high levels in pre-B cells, it raises the possibility that Fli-1b may be activated by E2A-PBX1 in these leukemias. It remains to be seen whether any of the consensus sequences for transcription factor binding sites play a role in the regulation of Fli-1b in vivo.
Promoter activity
The functional activity of the human Fli-1b promoter and its 5'-deletion constructs was tested in QT-6 cells by the calcium phosphate transfection method. The schematic diagram of the deletion constructs made is shown in Figure 5a . The full-length promoter construct pCAT-2870 did not show any signi®cant transcriptional activity (Figure 5b) . However, the pCAT-1133 construct showed twofold activity compared to vector. Further, deletion of 723 nucleotides (pCAT-410) dramatically increased the transcriptional activation to nearly eightfold. pCAT-150 which lost 260 nucleotides compared to pCAT-410 completely lost the transactivation property. The promoter region between nucleotides 7410 to 7150 constitutes the minimum promoter region necessary for maximum promoter function. Parallel experiments conducted in our laboratory and in another laboratory (Barbeau et al., 1996) using normal Fli-1 promoter constructs showed that the normal Fli-1 promoter is a weak transcriptional activator compared to Fli-1b promoter (data not shown). The genomic organization of Fli-1 and Fli-1b promoters are shown in Figure 5c .
Discussion
The Fli-1 gene, a target of insertional dysregulation by Friend erythroleukemia virus was recently found to be rearranged in the Ewing family of tumors carrying t(11;22)(q24;q12) chromosomal translocation (Delattre et al., 1992) . The present study is aimed at characterizing the regulatory sequences of the human libraries with erg probe and analysis of the cDNA sequences revealed alternative splicing and the presence of dierent 5'-ends in Fli-1 transcripts (Fli-1 and Fli1b). The exon-1 of the Fli-1 gene, which encodes the ®rst six amino acids and most of the 5'-UTR is replaced in Fli-1b with dierent 5'-sequence present at 1.4 kb upstream region resulting in a shorter reading frame with only 419 amino acids. Interestingly, the 5'-untranslated region of splice variant Fli-1b gene showed high homology with the 5'-sequences of mouse gene reported recently (Barbeau et al., 1996) . A similar observation was also made earlier with Fli-1 (Prasad et al., 1992) . This ®nding suggests that the conserved 5'-untranslated region of Fli-1b may play an important role in the post-transcriptional regulation of the Fli-1b transcripts.
Recently another aberrant transcript of human Fli-1 gene has been isolated from neuroepithelioma . In this aberrant transcript, the ®rst 49 amino acids of the normal Fli-1 gene are replaced by a novel exon, encoding only 11 amino acid residues. Northern blot analysis for the Fli-1b transcript, revealed that Fli-1b is expressed in pre-B cell acute lymphocytic leukemic cell lines 697 and RCH-ACV carrying the t(1;19) chromosome transclocation but not in B cell leukemia carrying the t(14;18) chromosome translocation. Interestingly, Fli-1 transcripts (unlike Fli-1b) are expressed in hematopoietic lineages like, Molt-4, KG-1, 380 and 697 cell lines (data not shown) implying a role in hematopoiesis. Further, our transcriptional activation assays revealed that the loss of the ®rst exon which shifts the ORF to methionine at position 33 does not alter the transcriptional activation properties of Fli-1b protein. Previously we have identi®ed a 5'-ets domain/amino terminal transactivation domain in the human Fli-1 protein spanning residues 121 ± 271 (Prasad et al., 1992) . Removal of this domain resulted in 60% loss of transcriptional activity. As the Fli-1b protein still contains this region, it could maintain its full transcriptional activation function.
To better understand the positive and negative control mechanisms that underlie cell-speci®c gene expression and their regulation, we have asked whether the two isoforms arise from alternative splicing of a precursor mRNA initiated at a single promoter or whether a dierential promoter usage would account for the dierences in their expression patterns. To answer this question, we have screened the human genomic library using a 5'-end speci®c probe of Fli-1b and obtained a genomic clone which contains this region. Restriction mapping, sequencing and promoter functional assay experiments identi®ed functional promoter regions for Fli-1 and alternatively spliced Fli-1b isoforms. Absence of promoter activity with pCAT-2870 and pCAT-1133 constructs, extending 3.0 kb and 1.3 kb respectively from the exon indicates the lack of function of the endogenous promoter in these cells. Deletion analysis at the 5'-end of the promoter identi®ed a 260 bp region (nucleotides 7410 to 7150) which is functionally active. Comparison of the promoter activities of normal Fli-1 and Fli-1b revealed that the Fli-1b promoter is up to ®ve times more active than the Fli-1 promoter (data not shown). Further, a BLAST similarity search of the promoter sequence (spanning from 7280 to +416) showed 87% and 98% homology (at various regions) with previously described mouse and human Fli-1 5'-anking regions respectively (Barbeau et al., 1996) . These homologous regions are almost 1.5 kb away from the Fli-1 exon-1. Several genes like the IL-1 receptor gene (Ye et al., 1993) , have been described that show reduced promoter activities highly strengthened by a distant control element. The conserved promoter sequence in both human and mouse also further suggests the involvement of this region in Fli-1 gene regulation.
Analysis of the promoter region identi®ed several putative binding sites for known transcription factors. The promoter region directing the transcription of human Fli-1b mRNA exhibits multiple start sites, possibly because of the absence of TATA or CCAAT motifs. But it contains partially conserved TATA-like sequences at positions 242 and 348, which are conserved among mouse and human 5'-sequences, suggesting one of them is a probable initiation site. The Fli-1b promoter shows similarity to Fli-1 promoter by having G+C rich content and containing similar motifs for transcription factors. The various Ets Binding Sites may be involved in the auto-regulation of the Fli-1b promoter (like in other ets genes). The presence of EBS next to other regulatory elements like Myc-PEA-3, ATF/CREB-Ets-2, and Ap-1-Oct-3 may contribute to the combined regulation of the Fli-1 gene. Similar dual binding sites have been described in the ets-2 and ets-1 promoters (Mavrothalassitis et al., 1990; Jorcyk et al., 1991) . Three conserved GATA-1 elements are also present in the promoter region. However, it remains to be addressed if any of these regions play a role in Fli-1 gene regulation. Since E2A-PBX1 fusion protein is activated in the pre-B cell acute lymphocytic leukemic cell lines 697 and RCH-ACV carrying the t(1;19) chromosome translocation (Kamps et al., 1990; Nourse et al., 1990) , we analysed for target sequences of E2A-PBX1 in Fli-1b promoter. Our analysis revealed the presence of two such consensus target sequences, raising the possibility that Fli-1b may be activated by E2A-PBX1 in these pre-B cells. Since we have shown earlier that Fli-1 proteins inhibit apoptosis (Yi et al., 1997) , it is possible that Fli-1b may also regulate apoptosis like Fli-1; this may be the reason for the activation of Fli-1b in pre-B cell acute lymphocytic leukemic cells carrying the t(1;19) chromosome translocation. It is also possible that Fli1b plays a role in the dierentiation of pre-B cells through apoptosis. Similar regulation of dierentiation of T cells through apoptosis was observed earlier with ets-1 (Bories et al., 1995) .
It has been shown that the purine/pyrimidine rich regions present in Fli-1 and Ets-2 (Barbeau et al., 1996; Jorcyk et al., 1991) promoters are S1 nuclease-sensitive and form an H-DNA structure. In case of Fli-1 exon-1, the 35 nucleotide GA repeat elements forms a retroviral integration site (Barbeau et al., 1996) for CaS-Br-E induced tumors. Interestingly, the Fli-1b promoter region does not contain this GA repeat region. This further indicates that deletion of most of exon-1 in Fli-1 RNAs may contribute to Fli-1 activation/integration.
In summary, we conclude that human Fli-1 isoforms are generated by dierential splicing and alternative promoter usage; and regulation of Fli-1 promoter activity recruits additional cis-acting elements Fli-1b encodes a transcriptional activator PDK Dhulipala et al located in the Fli-1b promoter region 1.4 kb away from the normal Fli-1 exon-1. We believe that this distant regulatory region in¯uences Fli-1 gene expression and is essential for the promoter function. Our results also suggest that Fli-1b functions as a transcriptional activator and is expressed highly in pre-B cells and may play a key role in the growth, dierentiation and apoptosis of these cells.
Materials and methods
Isolation and sequencing of human Fli-1 cDNA clones
The human spleen (Clontech) and Molt-4 cDNA libraries were screened and probed with the randomly labeled erg-2 probe using standard methods (Sambrook et al., 1989) . Positive clones were isolated and subsequently plaque puri®ed; lambda DNAs were prepared from the candidate clones and the insert fragments were isolated and subcloned in pSG5 and M13 mp18 vectors at suitable restriction sites. The nucleotide sequence of the cDNA clones was determined by dideoxy chain termination method (Sambrook et al., 1989) .
Isolation and sequencing of genomic DNA clones
The human genomic library was screened with a 32 P-labeled 5'-end fragment of splice variant Fli-1 gene spanning 5'-UTR (nt 1 ± 98 in Figure 1 ), as described (Yi et al., 1997) . About 10 6 plaques from 30 plates were lifted on the Nytran membranes and hybridized. The phage DNAs from the positive clones isolated by secondary and tertiary screening (HGL #1 ± 10) were isolated by the plate lysate method. The genomic DNA inserts from the lambda DNA were released by digestion with EcoRI enzyme, and subjected to Southern blot analysis using a probe corresponding to a 5'-untranslated region of the Fli-1b gene. A clone with 6 kb insert (HGL #2) was found to contain the 5'-untranslated region of the Fli-1b gene. This cone was used for further characterization of the promoter region. A restriction map for this entire 6 kb fragment was generated by restriction fragment and Southern blot analyses. From the data obtained from this restriction mapping, the region containing the putative promoter region was sub-cloned in pBluescript KS + and the plasmid DNA was sequenced (Sambrook et al., 1989) .
In vitro RNA synthesis and translation DNAs were made and puri®ed (Qiagen) from the full length (Fli-1) and splice variant (Fli-1b) clones sub-cloned into the pSG5 plasmid vector. The plasmid DNA was linearized with appropriate restriction enzymes and capped cRNA was synthesized in vitro (Melton, 1987) using suitable RNA polymerase. The quality of cRNA was tested in ethidium bromide stained agarose gels and quantitated by spectrophotometry and was translated in vitro using a rabbit reticulocyte lysate system (Promega) in the presence of [ 35 S]-L-Methionine. The labeled proteins were analysed by 10% SDS ± PAGE and autoradiography. The molecular weights of the proteins were determined by comparing with known standard markers run simultaneously.
Isolation and analysis of RNA Northern blot analysis Total and Poly(A) + RNA were isolated from Molt-4, Colo 320, 697, 380 and KG-1 cells by the single step GITC method and Oligo-dT cellulose chromatography. Five mg of these RNAs and an RNA ladder (GIBCO-BRL) were run on a 1.2% formaldehyde gel and transferred to Nytran paper (Schuell and Schleicher). The blot was hybridized with random labeled 5'-end probe of Fli-1b fragment (nt 1 ± 198), washed with 26SSC containing 1% SDS and subjected to autoradiography. The size of the transcript was determined by comparing with standard RNA size markers. RACE ± PCR assays Total RNAs were isolated from KG-1 and 697 cells as mentioned earlier. Single strand cDNA was synthesized using 5'-RACE PCR kit (Clontech) by following the manufacturer's protocol. A gene-speci®c antisense primer (complementary to Fli-1a; nt 200-180) and adaptor primer (suppled with kit) were used as 3' and 5' primers respectively to synthesize cDNA. The ss-cDNA obtained was ligated to anchor primer using RNA ligase enzyme and the resultant mixture was used as a template for PCR. To determine the 5'-end of the Fli-1b gene, the anchor ligated cDNA was ampli®ed with 5'-anchor primer and 3'-Fli-1b [5'-GTCCACGCTCTCCGGACCACG-3' and complementary to nucleotides 785 to 7105 of Fli-1b] gene-speci®c reverse primer. The ampli®ed fragments were sequenced by the dideoxy chain termination method and were also run on 3% NuSieve Agarose gels and transferred onto a Nytran membrane. The membranes were probed with Fli-1b 5'-end speci®c probe (nt 1 ± 198; in Figure 1 ) and subjected to auto-radiography.
Transcriptional activation assays
Cell culture Cells were grown at 378C in humidi®ed air with 5% CO 2 . All cells were obtained from ATCC and maintained in the Dulbecco's Modi®ed Eagle's high glucose media or RPMI 1640 media supplemented with either 10% fetal bovine serum or 10% calf serum and 1% Penicillin-streptomycin antibiotic solutions.
Plasmid construction The DNAs used for transfection were made by the Qiagen method and quantitated by both UV-absorbance and ethidium bromide staining of agarose gels containing the DNA.
(A) cDNA constructs: To study the transcriptional activation property of Fli-1b protein, full length constructs of Fli-1 and Fli-1b (cloned in pSG5 expression vector) were co-transfected with E-74-TK-CAT (which contains three repeats of ETS binding target sequences), pCH110 reference plasmid (containing b-galactosidase gene) and carrier plasmid DNA (KS + vector) into NIH3T3 cells. (B) Promoter constructs: A genomic lambda DNA insert from positive clone (HGL #2) was subcloned in pBluescript KS + vector and the 5'-¯anking sequence of Fli-1b was derived from this 6 kb fragment. A 3.04 kb XbaI restriction fragment containing the putative Fli-1b promoter region (72870 to +171) was subcloned in promoter-less pCAT-enhancer vector. This parent construct (pCAT-2870) was used for making 5'-deletion constructs and promoter assays. pCAT-1133 deletion construct (containing sequences 71133 to +171) was made by removing EcoRI ± AccI fragment from pCAT-3401 construct (see Figure 3a) . Deletion constructs pCAT-410 (containing sequences 7410 to +171) and pCAT-150 (containing sequences 7150 to +171) were made by PCR ampli®cation and by cloning into pCAT-enhancer vector at HindIII and XbaI sites. All deletions made were con®rmed by nucleotide sequencing and restriction cutting.
QT-6 (quail ®broblasts) cells were transfected with 5 mg of promoter plasmid DNAs and 5 mg of pCH 110 reference plasmid DNA (containing b-galactosidase gene) and 10 mg of Gem-3 DNA to make up 20 mg of ®nal DNA concentration.
DNA transfection and CAT assays For transfection experiments, the cells were seeded at a density of 8610 calcium phosphate co-precipitation method (Graham and Van der Eb, 1973) . The cells were washed and fresh media was added 24 h after transfection. After 48 h of incubation, the cells were harvested and extracts were assayed for b-galactosidase activity to normalize the transfection eciency. Cell extracts containing equal amounts of bgalactosidase activity were taken for CAT activity. CATassays were conducted using [ 14 C]chloramphenicol and acetyl co-enzyme A as the substrates, as described by Gorman et al. (1982) . The acetylated forms of chloramphenicol were separated by thin layer chromatography and subjected to autoradiography. The extent of conversion was quantitated by counting the silica gel portions in the LKB-liquid scintillation system (Pharmacia).
